Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients

2008589 citationsJournal Article

Authors

Felix Zeppernick · Heidelberg University

Rezvan Ahmadi · Heidelberg University

Benito Campos · Heidelberg University

Christine Dictus · Heidelberg University

Burkhard Helmke · Heidelberg University

Natália Becker · Heidelberg University

Peter Lichter ·

Abstract

These findings constitute the first conclusive evidence that CD133 stem cell antigen expression correlates with patient survival in gliomas, lending support to the current cancer stem cell hypothesis.

Topics & Keywords

Cancer Cells and Metastasis Glioma Diagnosis and Treatment Microtubule and mitosis dynamics

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Clinical Cancer Research

Volume 14, Issue 1, pp. 123-129

DOI: 10.1158/1078-0432.ccr-07-0932

Field-Weighted Citation Impact: 27.81